FHIR © HL7.org  |  FHIRsmith 4.0.1  |  Server Home  |  XIG Home  |  XIG Stats  | 

FHIR IG analytics

ValueSets, Realm US

14,205 resources

Source: Text:

By Version

By Authority

  • none: 1,983
  • hl7: 12,222

 

Start Prev Rows 800 - 1000 Next

PackageVersionIdentityName/TitleStatusFMMWGDateAuthSource(s)
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.186.jsonBeta blockers GDMT for heart failureactive2023-12hl7rx
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.188.jsonmedications_heart failureactive2024-12hl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.197.jsonBlood (Serum and Plasma) Potassiumactive2023-11hl7loinc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.214.jsonType 1 Diabetes Mellitus SCTactive2023-07hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.238.jsonMRA mineralocorticoid receptor antagonistsactive2024-10hl7rx
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.244.jsonMRA Mineralocorticoid Receptor Antagonist Allergyactive2023-06hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.260.jsonUACR SCTactive2023-07hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.263.jsonPregnancy I10active2023-11hl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.281.jsonStatins Allergy SCTactive2023-03hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.282.jsonStatin Allergy Intoleranceactive2025-04hl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.314.jsonrelatedconditions_hyperlipidemia I10active2023-10hl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.337.jsonMigraine I10active2023-03hl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.34.jsonBlood pressure panelactive2024-04hl7loinc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.35.jsonSystolic Blood Pressureactive2024-04hl7loinc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.367.jsonTrandolaprilactive2024-12hl7rx
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.369.jsonCandesartanactive2023-07hl7rx
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.377.jsonValsartanactive2023-07hl7rx
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.397.jsoneGFRactive2025-03hl7loinc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.412.jsonStatin Moderate Intensityactive2024-08hl7rx
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.415.jsonLDL Cholesterolactive2024-02hl7loinc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.43.jsonUrinalysisactive2024-02hl7loinc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.434.jsonInsulinactive2025-02hl7rx
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.437.jsonTZD Thiazolidinedionesactive2025-05hl7rx
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.438.jsonmedications_T2DMactive2023-08hl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.440.jsonrelatedconditions_T2DM SCTactive2023-09hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.442.jsonBlood Glucoseactive2024-07hl7loinc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.459.jsonLiver canceractive2023-07hl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.47.jsonACE inhibitor allergy SCTactive2022-08hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.474.jsonAllergy to Tdap Vaccineactive2023-06hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.475.jsonAllergy to Td Vaccineactive2023-06hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.481.jsonmedications_hypertensionactive2024-12hl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.492.jsonInhaled Corticosteroids Allergyactive2023-07hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.498.jsonMetformin AllergyIntolerance SCTactive2023-09hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.508.jsonAbdominal aortic imaging CPTactive2023-07hl7cpt
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.517.jsonHemoglobin A1cactive2024-03hl7loinc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.518.jsonDrug hypersensitivity I10active2023-07hl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.519.jsonDrug hypersensitivity SCTactive2023-07hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.520.jsonDrug hypersensitivityactive2023-07hl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.521.jsonDiabetic Kidney Disease I10active2023-07hl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.523.jsonDiabetic kidney diseaseactive2023-07hl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.524.jsonChronic Hepatitis SCTactive2023-07hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.525.jsonChronic Hepatitisactive2023-07hl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.527.jsonOCS_Prednisoneactive2024-12hl7rx
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.531.jsonAnti IgE Medicationsactive2023-07hl7rx
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.532.jsonIL5 Antagonistsactive2023-07hl7rx
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.533.jsonMast cell stabilizers for asthmaactive2023-07hl7rx
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.534.jsonVasospastic disease I10active2023-08hl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.535.jsonVasospastic disease SCTactive2023-07hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.536.jsonVasospastic diseaseactive2023-07hl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.537.jsonHemiplegic and basilar migraine I10active2023-07hl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.538.jsonHemiplegic and basilar migraine SCTactive2023-07hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.539.jsonHemiplegic and basilar migraineactive2023-07hl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.540.jsonPeptic ulcer disease I10active2023-07hl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.541.jsonPeptic ulcer disease SCTactive2023-07hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.542.jsonPeptic ulcer diseaseactive2023-07hl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.544.jsonBleeding disorder I10active2023-07hl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.545.jsonBleeding disorder SCTactive2023-07hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.548.jsonElectronic cigarettes or Vapingactive2023-07hl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.549.jsonBleeding disorderactive2023-07hl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.552.jsonTriptansactive2023-08hl7rx
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.553.jsonCGRP receptor antagonistsactive2023-08hl7rx
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.554.jsonDitansactive2023-08hl7rx
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.555.jsonErgotsactive2023-08hl7rx
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.556.jsonMigraine specific NSAIDsactive2023-08hl7rx
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.557.jsonOTC migraine analgesicsactive2023-08hl7rx
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.559.jsonmedications_migraine_acuteactive2023-11hl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.560.jsonrelatedconditions_migraine I10active2023-08hl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.561.jsonconditions_migraineactive2023-08hl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.562.jsonrelatedconditions_migraine SCTactive2023-08hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.563.jsonrelatedconditions_migraineactive2023-08hl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.564.jsonTriptan Allergy Intolerance SCTactive2023-08hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.565.jsonTriptan Allergy Intoleranceactive2025-04hl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.566.jsonIschemic bowel disease SCTactive2023-08hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.567.jsonIschemic bowel disease I10active2023-08hl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.568.jsonIschemic bowel diseaseactive2023-08hl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.573.jsonconditions_hyperlipidemia I10active2023-08hl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.574.jsonconditions_hyperlipidemia SCTactive2023-08hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.575.jsonconditions_hyperlipidemiaactive2023-08hl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.578.jsonPIM_Schedule Vactive2023-08hl7rx
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.580.jsonPIM_Acarboseactive2023-09hl7rx
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.582.jsonPIM_Dulaglutideactive2023-09hl7rx
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.583.jsonPIM_Glimepirideactive2023-09hl7rx
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.585.jsonPIM_Glucophageactive2023-08hl7rx
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.587.jsonPIM_Glucovanceactive2023-08hl7rx
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.588.jsonGlyburide PIMactive2023-08hl7rx
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.590.jsonAlpha glucosidase inhibitorsactive2023-08hl7rx
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.592.jsonAzotemiaactive2023-08hl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.594.jsonIntolerance to ARB SCTactive2023-09hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.595.jsonICS Lowactive2024-12hl7rx
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.596.jsonICS Mediumactive2023-08hl7rx
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.597.jsonICS Highactive2023-08hl7rx
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.598.jsonLow Dose ICS Formoterolactive2024-05hl7rx
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.600.jsonPIM_Vitamin B12 Level_LOINCactive2023-09hl7loinc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.601.jsonPIM_Vitamin B12 Level_CPTactive2023-09hl7cpt
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.604.jsonPIM_Glyburideactive2023-09hl7rx
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.605.jsonPIM_Pioglitazoneactive2023-09hl7rx
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.606.jsonPIM_Semaglutideactive2023-09hl7rx
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.607.jsonPIM_Linagliptinactive2023-09hl7rx
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.609.jsonMacrolide_Azithromycinactive2023-08hl7rx
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.61.jsonSecondary antihypertensivesactive2023-07hl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.610.jsonLong Acting Beta Agonists (LABA) Non_Formoterolactive2023-11hl7rx
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.612.jsonWolff Parkinson White SCTactive2023-09hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.613.jsonWolff Parkinson White I10active2023-09hl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.614.jsonWolff Parkinson Whiteactive2023-09hl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.615.jsonmedications_Asthmaactive2024-12hl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.619.jsonICS_LABA_LAMAactive2023-09hl7rx
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.620.jsonLow Dose ICS_LABA_Non Formoterolactive2024-06hl7rx
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.621.jsonMedium ICS_LABA Non Formoterolactive2023-11hl7rx
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.623.jsonLAMA Allergy SCTactive2023-09hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.624.jsonLABA Allergy SCTactive2023-09hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.625.jsonBetaBlock NonCS Secondary Allergy SCTactive2023-09hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.626.jsonEplerenone Allergy SCTactive2023-09hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.627.jsonSpironolactone Allergy SCTactive2023-09hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.628.jsonSGLT2 Inhibitors Allergy SCTactive2024-04hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.629.jsonPIM_Refill_Request_Antilipemics_LFTsactive2023-09hl7loinc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.630.jsonAngiotensin Receptor Neprilysin Inhibitor(ARNI) Allergy SCTactive2023-09hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.631.jsonPneumococcal Vaccine Allergy SCTactive2023-09hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.632.jsonMeglitinides Allergy SCTactive2024-04hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.633.jsonDPP4i Allergy SCTactive2024-04hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.635.jsonAlpha_glucosidase inhibitors allergy SCTactive2023-09hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.636.jsonGlucagon_Like Peptide 1 Receptor Agonist (GLP1RA) Allergy SCTactive2023-09hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.637.jsonInsulins Allergy SCTactive2023-09hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.638.jsonTZD Allergy SCTactive2024-04hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.639.jsonT2DM_Medications Allergy SCTactive2023-09hl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.642.jsonT2DM_Medications Allergy RXNORMactive2023-09hl7rx
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.643.jsonT2DM_Medications Allergy SNOMEDactive2023-09hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.646.jsonT2DM_Medication Allergy Intoleranceactive2023-09hl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.647.jsonStatins Allergy Intoleranceactive2023-09hl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.649.jsonACE Inhibitors Allergy Intoleranceactive2025-04hl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.650.jsonARB Allergy Intoleranceactive2025-04hl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.652.jsonLong Acting Muscarinic Antagonists (LAMA) Allergy Intoleranceactive2023-09hl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.653.jsonLong Acting Beta Agonists (LABA) Allergy Intoleranceactive2023-09hl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.654.jsonBetaBlocker NonCS Secondary Allergy Intoleranceactive2023-09hl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.656.jsonMRA Allergy Intoleranceactive2025-04hl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.657.jsonEplerenone Allergy Intoleranceactive2023-09hl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.658.jsonSpironolactone Allergy Intoleranceactive2023-09hl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.659.jsonSGLT2i Allergy Intoleranceactive2025-04hl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.660.jsonAngiotensin Receptor Neprilysin Inhibitor(ARNI) Allergy Intoleranceactive2023-09hl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.661.jsonTetanus, Diphtheria, Pertusis (Tdap) Vaccine Allergy Intoleranceactive2023-09hl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.665.jsonTetanus toxoid, diphtheria (Td) Vaccine Allergy Intoleranceactive2023-09hl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.666.jsonHuman Papillomavirus (HPV) vaccine Allergy Intoleranceactive2023-09hl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.667.jsonHerpes Zoster Vaccine Allergy Intoleranceactive2023-09hl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.670.jsonPneumococcal Vaccine Allergy Intoleranceactive2023-09hl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.671.jsonInhaled Corticosteroids(ICS) Allergy Intoleranceactive2023-09hl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.672.jsonLABA(Formoterol only)active2023-11hl7rx
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.674.jsonPIM_Tirzepatideactive2023-09hl7rx
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.675.jsonGLP1RA Allergy Intoleranceactive2025-04hl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.676.jsonPIM_Diabetes_Testing_Suppliesactive2025-05hl7cms
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.677.jsonPIM_H2_Antagonistsactive2023-09hl7rx
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.678.jsonSGLT2i DM CKDactive2023-10hl7rx
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.679.jsonSGLT2i DM ASCVDactive2023-10hl7rx
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.683.jsonOIA_Gout_Medicationsactive2025-05hl7rx
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.684.jsonGlumetzaSubstitutionactive2023-10hl7rx
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.685.jsonMetforminER500mgactive2023-10hl7rx
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.686.jsonPIM_Metforminactive2023-10hl7rx
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.687.jsonPIM_Glipizideactive2024-10hl7rx
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.689.jsonPIM_Glipizide_Glyburide_Glimepirideactive2024-11hl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.690.jsonPIM_Insulin_Meglitinidesactive2023-10hl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.691.jsonPIM_Glyxambiactive2023-10hl7rx
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.692.jsonPIM_Farxigaactive2023-10hl7rx
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.693.jsonPIM_Invokanaactive2023-10hl7rx
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.694.jsonPIM_Jardianceactive2023-10hl7rx
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.695.jsonPIM_Invokana_Jardianceactive2023-10hl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.696.jsonReclastactive2023-10hl7rx
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.697.jsonLAMA_LABA Combination 1 Inhaleractive2023-11hl7rx
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.698.jsonPIM_Contraceptivesactive2023-12hl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.699.jsonSelected Oral Antiemetics for Migraineactive2023-11hl7rx
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.700.jsonPIM_DEXA_Scanactive2023-12hl7loinc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.701.jsonPIM_DEXA_Scan_CPT_LOINCactive2023-12hl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.702.jsonPIM_SSRIsactive2023-12hl7rx
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.703.jsonPIM_SNRIsactive2023-12hl7rx
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.704.jsonPIM_NRIsactive2024-02hl7rx
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.705.jsonPIM_TCAsactive2023-12hl7rx
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.706.jsonPIM_Citalopramactive2023-12hl7rx
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.707.jsonPIM_Hydroxyzineactive2023-12hl7rx
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.708.jsonPIM_Buspironeactive2023-12hl7rx
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.709.jsonPIM_Bupropionactive2023-11hl7rx
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.710.jsonPIM_Mirtazapineactive2023-11hl7rx
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.711.jsonPIM_Trazodoneactive2023-11hl7rx
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.712.jsonPIM_IHD_CHD_CAD_ICD10active2023-11hl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.713.jsonPIM_IHD_CHD_CAD_SNOMEDactive2023-11hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.714.jsonPIM_Gabapentinactive2023-11hl7rx
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.715.jsonPIM_Allergy_Nasal_Spraysactive2023-11hl7rx
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.716.jsonPIM_Allergy_Oral_Medsactive2023-11hl7rx
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.717.jsonPIM_Allergy_Nasal_Oralactive2023-11hl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.719.jsonOCS_Prednisoloneactive2023-11hl7rx
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.72.jsonInhaled corticosteroids (IC)active2023-11hl7rx
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.720.jsonCOPD_Ofloxacinactive2023-11hl7rx
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.721.jsonCOPD_Ciprofloxacinactive2023-11hl7rx
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.722.jsonCOPD_Doxycyclineactive2023-11hl7rx
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.723.jsonMacrolide Allergy SCTactive2023-11hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.724.jsonMacrolide Allergy Intoleranceactive2025-04hl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.725.jsonPrednisone Allergy SCTactive2023-11hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.727.jsonTetracycline Allergy SCTactive2023-11hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.728.jsonTetracycline Allergy Intoleranceactive2023-11hl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.729.jsonFluoroquinolones Allergy SCTactive2023-11hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.730.jsonFluoroquinolone Allergy Intoleranceactive2023-11hl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.731.jsonPenicillin Allergy RXNORMactive2023-11hl7rx
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.732.jsonPenicillin Allergy SCTactive2023-11hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.733.jsonPenicillin Allergy Intoleranceactive2025-04hl7vsac